110 related articles for article (PubMed ID: 17338159)
1. CCNU for the treatment of dogs with histiocytic sarcoma.
Skorupski KA; Clifford CA; Paoloni MC; Lara-Garcia A; Barber L; Kent MS; LeBlanc AK; Sabhlok A; Mauldin EA; Shofer FS; Couto CG; Sørenmo KU
J Vet Intern Med; 2007; 21(1):121-6. PubMed ID: 17338159
[TBL] [Abstract][Full Text] [Related]
2. Primary histiocytic sarcoma of the hepatic.
Qin X; Yang X; Peng X
Asian J Surg; 2024 Jun; ():. PubMed ID: 38834479
[No Abstract] [Full Text] [Related]
3. Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.
Skorupski KA; Rodriguez CO; Krick EL; Clifford CA; Ward R; Kent MS
Vet Comp Oncol; 2009 Jun; 7(2):139-44. PubMed ID: 19453368
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
Cannon C; Borgatti A; Henson M; Husbands B
J Small Anim Pract; 2015 Jul; 56(7):425-9. PubMed ID: 25828786
[TBL] [Abstract][Full Text] [Related]
5. A review of histiocytic diseases of dogs and cats.
Moore PF
Vet Pathol; 2014 Jan; 51(1):167-84. PubMed ID: 24395976
[TBL] [Abstract][Full Text] [Related]
6. Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma.
Rassnick KM; Moore AS; Russell DS; Northrup NC; Kristal O; Bailey DB; Flory AB; Kiselow MA; Intile JL
J Vet Intern Med; 2010; 24(6):1528-31. PubMed ID: 21155191
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and prognostic factors in dogs with histiocytic sarcomas in Japan.
Takahashi M; Tomiyasu H; Hotta E; Asada H; Fukushima K; Kanemoto H; Fujino Y; Ohno K; Uchida K; Nakayama H; Tsujimoto H
J Vet Med Sci; 2014 May; 76(5):661-6. PubMed ID: 24441652
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma.
Klahn SL; Kitchell BE; Dervisis NG
J Am Vet Med Assoc; 2011 Jul; 239(1):90-6. PubMed ID: 21718201
[TBL] [Abstract][Full Text] [Related]
9. Clinical prognostic factors in canine histiocytic sarcoma.
Dervisis NG; Kiupel M; Qin Q; Cesario L
Vet Comp Oncol; 2017 Dec; 15(4):1171-1180. PubMed ID: 27334037
[TBL] [Abstract][Full Text] [Related]
10. Histiocytic sarcomas in flat-coated retrievers: a summary of 37 cases (November 1998-March 2005).
Fidel J; Schiller I; Hauser B; Jausi Y; Rohrer-Bley C; Roos M; Kaser-Hotz B
Vet Comp Oncol; 2006 Jun; 4(2):63-74. PubMed ID: 19754816
[TBL] [Abstract][Full Text] [Related]
11. Primary pulmonary histiocytic sarcoma in dogs: A retrospective analysis of 37 cases (2000-2015).
Marlowe KW; Robat CS; Clarke DM; Taylor A; Touret M; Husbands BD; Vail DM
Vet Comp Oncol; 2018 Dec; 16(4):658-663. PubMed ID: 30246460
[TBL] [Abstract][Full Text] [Related]
12. Canine histiocytic neoplasia: an overview.
Fulmer AK; Mauldin GE
Can Vet J; 2007 Oct; 48(10):1041-3, 1046-50. PubMed ID: 17987966
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes in dogs with localized splenic histiocytic sarcoma treated with splenectomy with or without adjuvant chemotherapy.
Latifi M; Tuohy JL; Coutermarsh-Ott SL; Klahn SL; Leeper H; Dervisis N
J Vet Intern Med; 2020 Nov; 34(6):2645-2650. PubMed ID: 32986268
[TBL] [Abstract][Full Text] [Related]
14. Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma.
Thamm DH; Vail DM; Post GS; Fan TM; Phillips BS; Axiak-Bechtel S; Elmslie RS; Klein MK; Ruslander DA
J Vet Intern Med; 2017 May; 31(3):872-878. PubMed ID: 28370378
[TBL] [Abstract][Full Text] [Related]
15. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
[TBL] [Abstract][Full Text] [Related]
16. Nimustine Treatment of 11 Cases of Canine Histiocytic Sarcoma.
Tani H; Kurita S; Miyamoto R; Sawada H; Fujiwara-Igarashi A; Michishita M; Azakami D; Hasegawa D; Tamura K; Bonkobara M
J Am Anim Hosp Assoc; 2020; 56(3):146. PubMed ID: 32182105
[No Abstract] [Full Text] [Related]
17. Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy.
Mason SL; Finotello R; Blackwood L
Vet Comp Oncol; 2018 Mar; 16(1):E30-E37. PubMed ID: 28621004
[TBL] [Abstract][Full Text] [Related]
18. The immunotherapy of canine osteosarcoma: a historical and systematic review.
Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(3):759-69. PubMed ID: 25929293
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases.
O'Connell K; Thomson M
Vet Comp Oncol; 2013 Mar; 11(1):51-62. PubMed ID: 22235766
[TBL] [Abstract][Full Text] [Related]
20. Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.
Rassnick KM; Bailey DB; Malone EK; Intile JL; Kiselow MA; Flory AB; Barlow LL; Balkman CE; Barnard SM; Waite AH
Vet Comp Oncol; 2010 Dec; 8(4):243-53. PubMed ID: 21062406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
